UBS Group AG Trims Position in Sotera Health Company $SHC

UBS Group AG reduced its holdings in Sotera Health Company (NASDAQ:SHC) by 13.3% during the 4th quarter, Holdings Channel reports. The fund owned 441,511 shares of the company’s stock after selling 67,754 shares during the period. UBS Group AG’s holdings in Sotera Health were worth $7,788,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. True Wealth Design LLC lifted its position in Sotera Health by 389.3% during the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock valued at $32,000 after purchasing an additional 1,456 shares during the period. Versant Capital Management Inc grew its position in Sotera Health by 117.6% during the 3rd quarter. Versant Capital Management Inc now owns 2,535 shares of the company’s stock worth $40,000 after purchasing an additional 1,370 shares during the period. EverSource Wealth Advisors LLC grew its position in Sotera Health by 831.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after purchasing an additional 2,935 shares during the period. Fairway Wealth LLC purchased a new position in shares of Sotera Health during the 3rd quarter valued at about $57,000. Finally, GAMMA Investing LLC lifted its holdings in shares of Sotera Health by 31.1% in the 4th quarter. GAMMA Investing LLC now owns 4,892 shares of the company’s stock valued at $86,000 after buying an additional 1,161 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Price Performance

Shares of NASDAQ SHC opened at $15.35 on Tuesday. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82. The firm has a fifty day moving average of $14.88 and a 200 day moving average of $16.42. The firm has a market cap of $4.38 billion, a PE ratio of 37.44 and a beta of 1.82. Sotera Health Company has a one year low of $10.80 and a one year high of $19.85.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.01. The business had revenue of $280.05 million for the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The company’s revenue was up 10.0% compared to the same quarter last year. During the same period last year, the firm posted $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, research analysts predict that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Piper Sandler restated an “overweight” rating and issued a $22.00 target price (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. Citigroup boosted their price target on Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a report on Tuesday, February 24th. Zacks Research lowered Sotera Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Barclays dropped their price objective on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Finally, Wall Street Zen lowered shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Seven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $20.33.

Insider Transactions at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of Sotera Health stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 15.36% of the company’s stock.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.